AR064419A1 - Composiciones farmaceuticas - Google Patents
Composiciones farmaceuticasInfo
- Publication number
- AR064419A1 AR064419A1 ARP070105696A ARP070105696A AR064419A1 AR 064419 A1 AR064419 A1 AR 064419A1 AR P070105696 A ARP070105696 A AR P070105696A AR P070105696 A ARP070105696 A AR P070105696A AR 064419 A1 AR064419 A1 AR 064419A1
- Authority
- AR
- Argentina
- Prior art keywords
- pharmaceutical compositions
- pharmaceutically acceptable
- pharmaceutical composition
- acceptable acid
- gelatin capsule
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4741—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Una composicion farmacéutica en la forma de una cápsula de gelatina, la cual comprende un ácido farmacéuticamente aceptable.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06126698 | 2006-12-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR064419A1 true AR064419A1 (es) | 2009-04-01 |
Family
ID=37890457
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP070105696A AR064419A1 (es) | 2006-12-20 | 2007-12-18 | Composiciones farmaceuticas |
Country Status (15)
Country | Link |
---|---|
US (1) | US20100068265A1 (es) |
EP (1) | EP2120889A1 (es) |
JP (1) | JP2010513351A (es) |
KR (1) | KR20090094373A (es) |
CN (1) | CN101563072A (es) |
AR (1) | AR064419A1 (es) |
AU (1) | AU2007334856A1 (es) |
BR (1) | BRPI0720489A2 (es) |
CA (1) | CA2672400A1 (es) |
CL (1) | CL2007003698A1 (es) |
MX (1) | MX2009006735A (es) |
PE (1) | PE20081482A1 (es) |
TW (1) | TW200833375A (es) |
UY (1) | UY30810A1 (es) |
WO (1) | WO2008074479A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5829607B2 (ja) * | 2010-06-30 | 2015-12-09 | 持田製薬株式会社 | ω3脂肪酸の配合製剤 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60239418A (ja) * | 1984-05-15 | 1985-11-28 | Nippon Kayaku Co Ltd | エトポシド軟カプセル製剤 |
DE4001622A1 (de) * | 1990-01-20 | 1991-07-25 | Thomae Gmbh Dr K | Orale arzneimittelformen von pimobendan |
US5620704A (en) * | 1994-11-07 | 1997-04-15 | Warner-Lambert Company | Process for stabilizing gelatin products |
US5726181A (en) * | 1995-06-05 | 1998-03-10 | Bionumerik Pharmaceuticals, Inc. | Formulations and compositions of poorly water soluble camptothecin derivatives |
AU1925697A (en) * | 1996-03-12 | 1997-10-01 | Novartis Ag | Filled gelatin capsules having a reduced degree of cross-linking |
US6228894B1 (en) * | 1998-04-17 | 2001-05-08 | Enhanced Derm Technologies, Inc. | Softgel-compatible composition containing retinol |
AU2003231126A1 (en) * | 2002-04-25 | 2003-11-10 | Banner Pharmacaps, Inc. | Chewable soft capsule |
NZ537022A (en) * | 2002-06-05 | 2006-10-27 | Ivax Pharmaceuticals S | Reduction of gelatin cross-linking in the gelatin shell of gelatin capsules by incorporating a free amino acid into the capsule shall and a carboxylic acid ester into the capsule filling |
-
2007
- 2007-12-14 PE PE2007001792A patent/PE20081482A1/es not_active Application Discontinuation
- 2007-12-18 KR KR1020097014926A patent/KR20090094373A/ko not_active Application Discontinuation
- 2007-12-18 AR ARP070105696A patent/AR064419A1/es unknown
- 2007-12-18 JP JP2009541867A patent/JP2010513351A/ja active Pending
- 2007-12-18 MX MX2009006735A patent/MX2009006735A/es not_active Application Discontinuation
- 2007-12-18 CN CNA2007800472119A patent/CN101563072A/zh active Pending
- 2007-12-18 US US12/518,958 patent/US20100068265A1/en not_active Abandoned
- 2007-12-18 EP EP07856861A patent/EP2120889A1/en not_active Withdrawn
- 2007-12-18 AU AU2007334856A patent/AU2007334856A1/en not_active Abandoned
- 2007-12-18 WO PCT/EP2007/011138 patent/WO2008074479A1/en active Application Filing
- 2007-12-18 CA CA002672400A patent/CA2672400A1/en not_active Abandoned
- 2007-12-18 BR BRPI0720489-2A patent/BRPI0720489A2/pt not_active Application Discontinuation
- 2007-12-19 UY UY30810A patent/UY30810A1/es not_active Application Discontinuation
- 2007-12-19 TW TW096148801A patent/TW200833375A/zh unknown
- 2007-12-19 CL CL200703698A patent/CL2007003698A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
BRPI0720489A2 (pt) | 2014-02-04 |
PE20081482A1 (es) | 2008-12-23 |
WO2008074479A1 (en) | 2008-06-26 |
US20100068265A1 (en) | 2010-03-18 |
MX2009006735A (es) | 2009-06-30 |
CN101563072A (zh) | 2009-10-21 |
KR20090094373A (ko) | 2009-09-04 |
TW200833375A (en) | 2008-08-16 |
UY30810A1 (es) | 2008-07-31 |
CA2672400A1 (en) | 2008-06-26 |
EP2120889A1 (en) | 2009-11-25 |
CL2007003698A1 (es) | 2008-07-18 |
JP2010513351A (ja) | 2010-04-30 |
AU2007334856A1 (en) | 2008-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201290982A1 (ru) | Фармацевтические композиции, препятствующие злоупотреблению | |
CY1117021T1 (el) | Φαρμακευτικες συνθεσεις οι οποιες περιεχουν νιλοτινιβη ή αλας αυτης | |
DK2254549T3 (da) | Vandige farmaceutiske sammensætninger, indeholdende borat-polyol-komplekser | |
BRPI0511900A (pt) | composições farmacêuticas | |
BRPI0810646A2 (pt) | " compostos farmacêuticos ". | |
HN2006014095A (es) | Forma cristalina ortorrombica del maleato de asenapina | |
BRPI0820997A2 (pt) | Comprimidos de desintegração oral compreendendo difenidramina. | |
BRPI0719398A2 (pt) | Composição farmacêutica. | |
DK2442790T3 (da) | Vandige farmaceutiske sammensætninger, indeholdende borat-polyolkomplekser | |
WO2007143651A3 (en) | Chewable co-enzyme q-10 capsule | |
NO20085302L (no) | Farmasoytisk preparat omfattende Amlodipin og Losartan | |
DK2033629T3 (da) | Fast farmaceutisk sammensætning omfattende valsartan | |
AR033711A1 (es) | Composiciones farmaceuticas | |
JP2009537554A5 (es) | ||
CY1110097T1 (el) | Διπλοστοιβαδικο δισκιο για προληψη καρδιαγγειακων συμβαντων | |
EA201170512A1 (ru) | Композиция для перорального введения | |
WO2008129501A3 (en) | Pharmaceutical compositions of duloxetine | |
TW200700062A (en) | Pharmaceutical compositions | |
BRPI0610156A2 (pt) | forma micronizada de um composto, forma purificada i do composto, kit, padrão de referência, e, método de preparaçao de uma composição farmacêutica. | |
CL2007003593A1 (es) | Composicion farmaceutica que comprende fluoresceina pura; procedimiento de preparacion de la fluoresceina. | |
IT1401284B1 (it) | Nuove formulazioni farmaceutiche idonee per la somministrazione orale di esomeprazolo magnesio diidrato, in forma di compresse mups (multi unit pellets system). | |
SM200500011B (it) | Una composizione farmaceutica antimicobatterica | |
ITFI20080016A1 (it) | Formulazioni farmaceutiche orali contenenti gliclazide. | |
ATE533477T1 (de) | Pharmazeutische zusammensetzungen enthaltend irbesartan | |
AR064419A1 (es) | Composiciones farmaceuticas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |